Hamdi et al. [54] analyzed circulating miRNA expression in inflammatory and non-inflammatory BC and described lower miR-15a serum levels in the HER2+ subtype, offering a distinctive element for such a BC subgroup. This evidence concerns the gene ERBB2 and breast cancer.